The Case for Remdesivir
Listen now
Description
This week, it was announced that the drug remdesivir, an antiviral medication developed by Gilead Sciences, had proven effective against COVID-19 in a major study. The drug was found to cut the time of patient recovery by an average of 4 days. Dr. Anthony Fauci has said that remdesivir will set a new "standard of care" for treatment of COVID-19. To learn more about the drug and the results of the study, Christina speaks with Dr. Terese Hammond, pulmonary critical care specialist and one of the principal investigators for the remdesivir trials.
More Episodes
Christina Pascucci heads out to Death Valley for an adventure to break the monotony of life amid coronavirus. She shares the natural wonders that can be found at one of the hottest places in the world, and learns about what the Oasis at Death Valley is doing to help keep people safe during their...
Published 08/21/20
XPRIZE is a non-profit organization that hosts competitions intended to encourage technological development to benefit humanity. The foundation is giving away a $5,000,000 prize to the team who can develop a rapid, reliable, and affordable COVID-19 test. The goal is to accelerate radical...
Published 08/14/20
The race is on to develop a vaccine to fight off COVID-19. Biotech company Moderna says they're on track to finish enrollment for a Phase-3 study of its vaccine by the end of September. Dr. Anthony Fauci, the nation's top infectious disease expert, says he remains "cautiously optimistic" in...
Published 08/07/20
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
